Purpose:To estimate the curative effects and side effects obtained from high-dose epirubicin (EPI) combination therapy in the treatment of advanced chest malignant tumors. Methods:Forty-eight cases with advanced chest malignant tumor(32 cases with non-small-cell lung cancer; eleven cases with breast cancer and five cases with mediastinal malignant lymphomas) were treated with the combination therapy of high-dose EPI. Results:The response rate in non-small-cell lung cancer was 56.3%, in breast cancer was 72.7%, in mediastinal malignant lymphomas was 100%. The most frequent toxicities were neutropenia.Conclusions:The combined chemotherapy of high-does EPI is an effective and safe treatment in advanced chest malignant tumor.

In this paper we synthesised two kinds of hydrophilic liquid crystal, i.e. cholesteryl triethenyl glycol carbonate (TCC), cholesteryl tetraethenyl glycol carbonate (TeCC), which were blended with PLA with certain contents to form composite membranes. Contact angle test showed that the contact angle decreases with the increase of liquid crystal. The blood-compatibility of the composite membranes was assessed by blood clotting time and hemolysis ratio which showed that these PLA/liquid crystal composite membranes with the content of 30%-40% liquid crystal appeared to be beneficial in improving the blood compatibility and anticoagulation.
Biocompatible Materials ; chemistry ; Blood Coagulation ; Lactic Acid ; Materials Testing ; Membranes, Artificial ; Polyesters ; Polymers